Precigen, Inc.
PGEN
$4.18
$0.5414.84%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 822.00K | 1.32M | 1.18M | 952.00K | 704.00K |
Total Other Revenue | 34.00K | 23.00K | 11.00K | 1.00K | 13.00K |
Total Revenue | 856.00K | 1.34M | 1.19M | 953.00K | 717.00K |
Cost of Revenue | 1.56M | 1.10M | 54.24M | 1.01M | 1.93M |
Gross Profit | -699.00K | 241.00K | -53.05M | -56.00K | -1.22M |
SG&A Expenses | 16.13M | 12.36M | 11.00M | 9.84M | 10.31M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 28.71M | 23.94M | 23.93M | 22.22M | 27.01M |
Operating Income | -27.86M | -22.60M | -22.74M | -21.26M | -26.30M |
Income Before Tax | -26.64M | -54.15M | -19.81M | -23.97M | -60.48M |
Income Tax Expenses | 3.00K | -- | -87.00K | 12.00K | -1.69M |
Earnings from Continuing Operations | -26.64M | -54.15M | -19.73M | -23.98M | -58.79M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -26.64M | -54.15M | -19.73M | -23.98M | -58.79M |
EBIT | -27.86M | -22.60M | -22.74M | -21.26M | -26.30M |
EBITDA | -27.23M | -21.97M | -22.08M | -20.59M | -24.70M |
EPS Basic | -0.09 | -0.18 | -0.07 | -0.09 | -0.23 |
Normalized Basic EPS | -0.05 | -0.12 | -0.05 | -0.05 | -0.06 |
EPS Diluted | -0.09 | -0.18 | -0.07 | -0.09 | -0.23 |
Normalized Diluted EPS | -0.05 | -0.12 | -0.05 | -0.05 | -0.06 |
Average Basic Shares Outstanding | 296.43M | 293.88M | 293.15M | 275.88M | 252.37M |
Average Diluted Shares Outstanding | 296.43M | 293.88M | 293.15M | 275.88M | 252.37M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |